SOPHiA GENETICS SA
SOPH- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- SEC CIK
- 0001840706
In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 36 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.
Superinvestors holding SOPH, Q2 2026
1 superinvestor reports holding SOPHiA GENETICS SA on Form 13F, worth $21.5M in total. Weight is SOPHiA GENETICS SA's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Akre Capital ManagementChuck Akre | 0.4% | 3,719,140 | $21.5M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SOPH each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2025
1 superinvestor holding at quarter end
- Added
- Akre Capital Management (+66.2%)
Q3 2024
1 superinvestor holding at quarter end
- Added
- Akre Capital Management (+16.5%)
Q2 2024
1 superinvestor holding at quarter end
- Added
- Akre Capital Management (+567.5%)
Q1 2024
1 superinvestor holding at quarter end